Why the study?
Does losartan improve biochemical and histological markers in patients with NASH and hypertension?
Population
7 patients with both nonalcoholic steatohepatitis (NASH) and hypertension
Design
Case_series
Follow-up
48 weeks
Authors
Loading...
Hypothesis-generating for losartan in NASH hypertension; does not support practice change pending randomized trials.
Does losartan improve biochemical and histological markers in patients with NASH and hypertension?
Losartan may improve biochemical and histological markers of liver injury and fibrosis in patients with NASH and hypertension.
Yokohama et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: